Natco Pharma Reports Flat December 2024 Results Amid Profit Decline and Low Sales

Feb 14 2025 06:00 PM IST
share
Share Via
Natco Pharma has recently experienced an evaluation adjustment reflecting its financial performance, reporting flat results for the quarter ending December 2024. The company faced a decline in profit after tax and net sales, yet it maintains strong management efficiency and healthy long-term growth, supported by significant institutional holdings.
Natco Pharma, a midcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation adjustment that reflects the current dynamics of its financial performance. The company reported flat financial results for the quarter ending December 2024, with a notable decline in profit after tax, which stood at Rs 133.00 crore, marking a significant drop compared to the previous four-quarter average. Additionally, net sales reached their lowest point at Rs 474.80 crore, while the profit before depreciation, interest, and taxes also recorded a low of Rs 38.80 crore.

Despite these challenges, Natco Pharma maintains a strong management efficiency, evidenced by a high return on equity of 15.27% and a low debt-to-equity ratio. The company has demonstrated healthy long-term growth, with operating profit increasing at an annual rate of 30.72%. Furthermore, it boasts a favorable valuation with a price-to-book ratio of 2.4, trading at a discount relative to its peers.

The stock's technical indicators suggest a bearish trend, influenced by various factors. However, the presence of high institutional holdings at 23.51% indicates a level of confidence from investors with substantial analytical resources.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News